Driscoll Frederick W insider trades
Driscoll Frederick W has filed 18 Form 4s with the SEC that we hold, for Cellectar Biosciences, Inc. (CLRB) (Director), Lite Strategy, Inc. (LITS) (Director), Cue Biopharma, Inc. (CUE) (Director) and FLXN (Chief Financial Officer), among 5 companies in all. Across all of them we count 1 purchase worth $20.2K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 19,417 shares of Cellectar Biosciences, Inc. worth $20.2K, dated 2021-09-03. The first filing on our record is dated 2021-07-02 and the latest 2026-07-08.
Cellectar Biosciences, Inc. (CLRB)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-03 | P, purchase reported on Form 4 | 19,417 | $20.2K | 2021-09-07 |
Lite Strategy, Inc. (LITS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Cue Biopharma, Inc. (CUE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
FLXN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
RCOR
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1129890) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms